LRDG — 27 Health Holdings Share Price
Last trade - 00:00- $0.00m
- $1.91m
- $0.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -228549.06% | ||
Financial Summary
| Year End 31st Jul | Unit | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0 | 0 | 0.08 | 0 | 0 | n/a | n/a | -18.27% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
27 Health Holdings Corp., formerly Lord Global Corporation, is focused on the business development of its 27Health Inc. subsidiary. 27Health Inc. is focused on financing and marketing, healthcare-related products. The Company distributes the Virolens product in Asia, Australia, New Zealand and other Oceania countries. The Virolens system is a COVID-19 screening device based on microscopic holographic imaging and artificial intelligence (AI) software technology. It uses a digital camera attached to a microscope to analyze saliva samples, with the data run through a computer that is trained to identify the virus from other cells, delivering a result in just 20 seconds. The Virolens system was trained to recognize the COVID-19 virus particles in saliva using a range of samples of COVID-19 virus provided by virologists working on the virus at the University of Bristol.
Directors
- Joseph Frontiere CEO (30)
- C. Thomas Biscardi DRC (46)
- Richard Fletcher DRC (76)
- Greta Goth DRC (85)
- Dennis Kazubowski DRC (57)
- Youssary Kelada DRC (61)
- Last Annual
- July 31st, 2019
- Last Interim
- April 30th, 2020
- Incorporated
- November 30th, 2011
- Public Since
- June 28th, 2016
- Sector
- Media & Publishing
- Industry
- Consumer Cyclicals
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,344,655
- Address
- 318 N CARSON ST, STE 208, CARSON CITY, 89701
- Web
- Phone
- +1 8163042686
- Auditors
- Malone Bailey, LLP
Upcoming Events for LRDG
Similar to LRDG
Diamond Energy Partners
Pink Sheets on Nasdaq
Ab International
Pink Sheets on Nasdaq
Abv Consulting
Pink Sheets on Nasdaq
Adaptive Ad Systems
Pink Sheets on Nasdaq
Adsouth Partners
Pink Sheets on Nasdaq
FAQ
As of Today at 19:13 UTC, shares in 27 Health Holdings are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in 27 Health Holdings last closed at $0.00 and the price had moved by -89.74% over the past 365 days. In terms of relative price strength the 27 Health Holdings share price has underperformed the S&P500 Index by -91.18% over the past year.
There is no consensus recommendation for this security.
27 Health Holdings does not currently pay a dividend.
27 Health Holdings does not currently pay a dividend.
27 Health Holdings does not currently pay a dividend.
To buy shares in 27 Health Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in 27 Health Holdings had a market capitalisation of $0.00m.
Here are the trading details for 27 Health Holdings:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: LRDG
Based on an overall assessment of its quality, value and momentum 27 Health Holdings is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 27 Health Holdings. Over the past six months, its share price has outperformed the S&P500 Index by +73.35%.
As of the last closing price of $0.00, shares in 27 Health Holdings were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The 27 Health Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
27 Health Holdings' management team is headed by:
- Joseph Frontiere - CEO
- C. Thomas Biscardi - DRC
- Richard Fletcher - DRC
- Greta Goth - DRC
- Dennis Kazubowski - DRC
- Youssary Kelada - DRC